vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2015-4-40-45vtio-589Research ArticleКлиническая трансплантологияClinical TransplantologyПРОТЕКТИВНЫЕ СВОЙСТВА СЕВОФЛЮРАНА ПРИ ИШЕМИЧЕСКИ-РЕПЕРФУЗИОННОМ ПОВРЕЖДЕНИИ ТРАНСПЛАНТИРОВАННОЙ ТРУПНОЙ ПОЧКИTHE PROTECTIVE PROPERTIES OF SEVOFLURANE AT ISCHEMIA-REPERFUSION INJURY OF TRANSPLANTED CADAVERIC KIDNEYХубутияМ. Ш.KhubutiaM. Sh.ЖуравельС. В.ZhuravelS. V.УткинаИ. И.UtkinaI. I.ПинчукА. В.PinchukA. V.КузнецоваН. К.KuznetsovaN. K.ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского», Москва, Российская ФедерацияРоссияN.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian FederationRussian FederationN.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian FederationRussian Federation2015130120161744045Copyright © Хубутия М.Ш., Журавель С.В., Уткина И.И., Пинчук А.В., Кузнецова Н.К., 20162016Хубутия М.Ш., Журавель С.В., Уткина И.И., Пинчук А.В., Кузнецова Н.К.Khubutia M.S., Zhuravel S.V., Utkina I.I., Pinchuk A.V., Kuznetsova N.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/589

В статье приведены протективные свойства севорана и пропофола при трансплантации почки. Для изучения этих свойств использовали микродиализную технологию. В исследование включены 40 пациентов. Пациенты были рандомизированы на 2 группы. Севоран обладает более эффективными нефропротективными свойствами при сравнении с пропофолом. 

The paper presents the renoprotective properties of sevoflurane and propofol in kidney transplantation. In order to study these properties microdialysis technology was used. The study included 40 patients. The patients were randomized in two groups. Sevoflurane had more effective renoprotective properties than propofol. 

ишемически-реперфузионное повреждениеанестетикитрансплантация почкиischemia reperfusion injuryanestheticskidney transplantationReferencesMessa P, Ponticelli C, Berardinelli L. Coming back to dialysis after kidney transplant failure. Nephrol Dial Transplant. 2008; 23; 9: 2738–2742.Messa P, Ponticelli C, Berardinelli L. Coming back to dialysis after kidney transplant failure. Nephrol Dial Transplant. 2008; 23; 9: 2738–2742.Danobeitia JS, Djamali A, Fernandez LA. The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair. 2014; 7: 16.Danobeitia JS, Djamali A, Fernandez LA. The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair. 2014; 7: 16.Khalid U, Bowen T, Fraser DJ, Jenkins RH. Acute kidney injury: a paradigm for miRNA regulation of the cell cycle. Biochem Soc Trans. 2014; 42; 4: 1219–1223.Khalid U, Bowen T, Fraser DJ, Jenkins RH. Acute kidney injury: a paradigm for miRNA regulation of the cell cycle. Biochem Soc Trans. 2014; 42; 4: 1219–1223.Rong S, Hueper K, Kirsch T. Renal PKC-ε deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-α-dependent inhibition of apoptosis and inflammation. Am J Physiol Renal Physiol. 2014; 307; 6: 718–726.Rong S, Hueper K, Kirsch T. Renal PKC-ε deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-α-dependent inhibition of apoptosis and inflammation. Am J Physiol Renal Physiol. 2014; 307; 6: 718–726.Cao Z, Zhang G, Wang F. Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS One. 2013; 8; 12: 829–849.Cao Z, Zhang G, Wang F. Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS One. 2013; 8; 12: 829–849.Shokeir A, Barakat N, Hussein A. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study. Physiol Res. 2015; 64 (3): 313–23. PMID: 25536319.Shokeir A, Barakat N, Hussein A. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study. Physiol Res. 2015; 64 (3): 313–23. PMID: 25536319.Liang Y, Li Z, Mo N. Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats. Biol Pharm Bull. 2014; 37; 10: 1599–1605.Liang Y, Li Z, Mo N. Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats. Biol Pharm Bull. 2014; 37; 10: 1599–1605.Qin Z, Lv E, Zhan L. Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiol. 2014; 14: 28–30.Qin Z, Lv E, Zhan L. Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiol. 2014; 14: 28–30.Хубутия МШ, Журавель СВ, Романов АА. Ранняя оценка функции почечного аллотрансплантата в периоперационном периоде методом микродиализа. Трансплантология. 2014; 1: 20–23. Hubutija MS, Zhuravel' SV, Romanov AA. Rannjaja ocenka funkcii pochechnogo allotransplantata v perioperacionnom periode metodom mikrodializa. Transplantologija. 2014; 1: 20–23.Хубутия МШ, Журавель СВ, Романов АА. Ранняя оценка функции почечного аллотрансплантата в периоперационном периоде методом микродиализа. Трансплантология. 2014; 1: 20–23. Hubutija MS, Zhuravel' SV, Romanov AA. Rannjaja ocenka funkcii pochechnogo allotransplantata v perioperacionnom periode metodom mikrodializa. Transplantologija. 2014; 1: 20–23.Cekauskas A, Bruns H, Manikas M. Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damage Ann Transplant. 18: 488–496.Cekauskas A, Bruns H, Manikas M. Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damage Ann Transplant. 18: 488–496.Zhou S, Jiang P, Liu L, Liu H. Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study. Eur J Anaesthesiol. 2013; 30 (10): 612–617. doi: 10.1097/EJA.0b013e3283614023.Zhou S, Jiang P, Liu L, Liu H. Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study. Eur J Anaesthesiol. 2013; 30 (10): 612–617. doi: 10.1097/EJA.0b013e3283614023.Soro M, Gallego L, Silva V. Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomised study. Eur J Anaesthesiol. 2012; 29; 12: 561–569.Soro M, Gallego L, Silva V. Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomised study. Eur J Anaesthesiol. 2012; 29; 12: 561–569.Zhang J, Wang C, Yu S. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014; 4: 71–73.Zhang J, Wang C, Yu S. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014; 4: 71–73.Bettex D, Wanner P, Bosshart M. Role of sevoflurane in organ protection during cardiac surgery in children: a randomized controlled trial. Interact Cardiovasc Thorac Surg. 2015; 20; 2: 157–165.Bettex D, Wanner P, Bosshart M. Role of sevoflurane in organ protection during cardiac surgery in children: a randomized controlled trial. Interact Cardiovasc Thorac Surg. 2015; 20; 2: 157–165.Fudickar A, Kunath S, Voß D. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy – a pilot study. BMC Anesthesiol. 2014; 14: 54–57.Fudickar A, Kunath S, Voß D. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy – a pilot study. BMC Anesthesiol. 2014; 14: 54–57.Лихванцев ВВ, Мороз ВВ, Гребенчиков ОА. Ишемическое и фармакологическое прекондиционирование. Общая реаниматология. 2012; 1: 61–66. Lihvancev VV, Moroz VV, Grebenchikov OA. Ishemicheskoe i farmakologicheskoe prekondicionirovanie. Obshсhaja reanimatologija. 2012; 1: 61–66.Лихванцев ВВ, Мороз ВВ, Гребенчиков ОА. Ишемическое и фармакологическое прекондиционирование. Общая реаниматология. 2012; 1: 61–66. Lihvancev VV, Moroz VV, Grebenchikov OA. Ishemicheskoe i farmakologicheskoe prekondicionirovanie. Obshсhaja reanimatologija. 2012; 1: 61–66.Мороз ВВ, Борисов КЮ, Гребенчиков ОА. Анестетическое прекондиционирование миокарда и некоторые биохимические маркеры сердечной и коронарной недостаточности после операций аортокоронарного шунтирования. Общая реаниматология. 2013; 5: 29–35. Moroz VV, Borisov KJ, Grebenchikov OA. Anesteticheskoe prekondicionirovanie miokarda i nekotorye biohimicheskie markery serdechnoj i koronarnoj nedostatochnosti posle operacij aortokoronarnogo shuntirovanija. Obshсhaja reanimatologija. 2013; 5: 29–35.Мороз ВВ, Борисов КЮ, Гребенчиков ОА. Анестетическое прекондиционирование миокарда и некоторые биохимические маркеры сердечной и коронарной недостаточности после операций аортокоронарного шунтирования. Общая реаниматология. 2013; 5: 29–35. Moroz VV, Borisov KJ, Grebenchikov OA. Anesteticheskoe prekondicionirovanie miokarda i nekotorye biohimicheskie markery serdechnoj i koronarnoj nedostatochnosti posle operacij aortokoronarnogo shuntirovanija. Obshсhaja reanimatologija. 2013; 5: 29–35.Beck-Schimmer B, Breitenstein S, Bonvini J. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012; 256; 5: 837–844.Beck-Schimmer B, Breitenstein S, Bonvini J. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012; 256; 5: 837–844.Lucchinetti E, Ambrosio S, Aguirre J. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007; 106; 2: 262–268.Lucchinetti E, Ambrosio S, Aguirre J. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007; 106; 2: 262–268.Swyers T, Redford D, Larson D. Volatile anesthetic-induced preconditioning. Perfusion. 2014; 29; 1: 10–15.Swyers T, Redford D, Larson D. Volatile anesthetic-induced preconditioning. Perfusion. 2014; 29; 1: 10–15.Movafagh S, Crook S, Vo KJ. Regulation of HypoxiaInducible Factor-1a by Reactive Oxygen Species: New Developments in an Old Debate. Cell Biochem. 2015; 116 (5): 696–703. doi: 10.1002/jcb.25074.Movafagh S, Crook S, Vo KJ. Regulation of HypoxiaInducible Factor-1a by Reactive Oxygen Species: New Developments in an Old Debate. Cell Biochem. 2015; 116 (5): 696–703. doi: 10.1002/jcb.25074.Bocanegra V, Gil Lorenzo AF, Cacciamani V. RhoA and MAPK signal transduction pathways regulate NHE1-dependent proximal tubule cell apoptosis after mechanical stretch. Am J Physiol Renal Physiol. 2014; 307; 7: 881–889.Bocanegra V, Gil Lorenzo AF, Cacciamani V. RhoA and MAPK signal transduction pathways regulate NHE1-dependent proximal tubule cell apoptosis after mechanical stretch. Am J Physiol Renal Physiol. 2014; 307; 7: 881–889.Wang H, Liu S, Wang H. The effect of propofol postconditioning on the expression of KCl co-transporter 2 in GABAergic inhibitory interneurons of acute ischemia/ reperfusion injury rats Brain Res. 2015; 1597: 210–219. doi: 10.1016/j.brainres.2014.11.036.Wang H, Liu S, Wang H. The effect of propofol postconditioning on the expression of KCl co-transporter 2 in GABAergic inhibitory interneurons of acute ischemia/ reperfusion injury rats Brain Res. 2015; 1597: 210–219. doi: 10.1016/j.brainres.2014.11.036.Mahajan C, Chouhan RS, Rath GP. Effect of intraoperative brain protection with propofol on postoperative cognition in patients undergoing temporary clipping during intracranial aneurysm surgery. Neurol India. 2014; 62; 3: 262–268.Mahajan C, Chouhan RS, Rath GP. Effect of intraoperative brain protection with propofol on postoperative cognition in patients undergoing temporary clipping during intracranial aneurysm surgery. Neurol India. 2014; 62; 3: 262–268.Jovic M, Stancic A, Nenadic D. Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass. Cell Physiol Biochem. 2012; 29; 2: 131–142.Jovic M, Stancic A, Nenadic D. Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass. Cell Physiol Biochem. 2012; 29; 2: 131–142.Schifilliti D, Grasso G, Conti A. Anaesthetic-related neuroprotection: intravenous or inhalational agents. CNS Drugs. 2010; 24; 11: 893–907.Schifilliti D, Grasso G, Conti A. Anaesthetic-related neuroprotection: intravenous or inhalational agents. CNS Drugs. 2010; 24; 11: 893–907.Bruhl SR, Vetteth S, Rees M. Post-reperfusion syndrome during renal transplantation: a retrospective study. Int J Med Sci. 2012; 9; 5: 391–396.Bruhl SR, Vetteth S, Rees M. Post-reperfusion syndrome during renal transplantation: a retrospective study. Int J Med Sci. 2012; 9; 5: 391–396.Nafar M, Sahraei Z, Salamzadeh J. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis. 2011; 5; 6: 357–372.Nafar M, Sahraei Z, Salamzadeh J. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis. 2011; 5; 6: 357–372.Snoeijs MG, Bijnen A, Swennen E. Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation. Ann Surg. 2011; 253; 3: 598–604.Snoeijs MG, Bijnen A, Swennen E. Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation. Ann Surg. 2011; 253; 3: 598–604.Журавель СВ, Романов АА, Гончарова ИИ. Перспективы применения микродиализной технологии в клинической трансплантологии. Высокотехнологичная медицина. 2014; 1: 24–29. Zhuravel' SV, Romanov AA, Goncharova II. Perspektivy primenenija mikrodializnoj tehnologii v klinicheskoj transplantologii. Vysokotehnologichnaja medicina. 2014; 1: 24–29.Журавель СВ, Романов АА, Гончарова ИИ. Перспективы применения микродиализной технологии в клинической трансплантологии. Высокотехнологичная медицина. 2014; 1: 24–29. Zhuravel' SV, Romanov AA, Goncharova II. Perspektivy primenenija mikrodializnoj tehnologii v klinicheskoj transplantologii. Vysokotehnologichnaja medicina. 2014; 1: 24–29.

The authors declare that there are no conflicts of interest present.